IQV Q1 2024 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena

IQVIQVIA Holdings Inc.

$30B

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.7B+2.3% YoY

Gross Profit

$1.3B34.6% margin

Operating Income

$506M13.5% margin

Net Income

$288M7.7% margin

EPS (Diluted)

$1.56

QoQ Revenue Growth

-3.4%

Cash Flow

Operating Cash Flow

$522M

Free Cash Flow

$377M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$26.6B

Total Liabilities

$20.2B

Stockholders' Equity

$6.3B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.7B	$3.7B	+2.3%
Gross Profit	$1.3B	$1.3B	+3.1%
Operating Income	$506M	$471M	+7.4%
Net Income	$288M	$289M	-0.3%

Revenue Segments

Research And Development Solutions

$2.1B56%

Technology And Analytics Solutions

$1.5B39%

Contract Sales And Medical Solutions

$189M5%

Geographic Segments

Americas

$1.8B48%

EMEA

$1.2B31%

Asia Pacific

$778M21%